Triple Therapy Reduces Mortality and CV Risk in COPD

This presentation explores Triple Therapy in COPD, beginning with an overview of its impact and current treatments. The methodology discusses study inclusion criteria, search strategies, and analytical techniques. Primary findings highlight reduced mortality, fewer exacerbations, and lower cardiovascular event risks. Subgroup analyses evaluate BGF regimen efficacy, assess non-BGF therapies, and address heterogeneity issues. Concluding remarks emphasize the potential for personalized therapy...